Overview

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

Status:
Terminated

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

To analyze the pathological tumor response on resected colorectal cancer metastases after preoperative treatment with cetuximab combined with FOLFOX or FOLFIRI regimen in a prospective cohort (RAS and B-RAF WT tumors) and to correlate this response with patient's outcome.

Phase:

Phase 2

Details

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborator:

Grand Hôpital de Charleroi

Treatments:

Camptothecin
Cetuximab
Irinotecan
Leucovorin
Oxaliplatin